Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.
Ye G, Gallant JP, Massey C, Shi K, Tai W, Zheng J, Odle AE, Vickers MA, Shang J, Wan Y, Drelich A, Kempaiah KR, Tat V, Perlman S, Du L, Tseng CT, Aihara H, LeBeau AM, Li F. Ye G, et al. Among authors: perlman s. bioRxiv [Preprint]. 2020 Nov 17:2020.11.17.386532. doi: 10.1101/2020.11.17.386532. bioRxiv. 2020. Update in: Elife. 2021 Aug 02;10:e64815. doi: 10.7554/eLife.64815. PMID: 33236012 Free PMC article. Updated. Preprint.
Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W, Wang Y, Fett CA, Zhao G, Li F, Perlman S, Jiang S, Zhou Y, Du L. Tai W, et al. Among authors: perlman s. J Virol. 2016 Dec 16;91(1):e01651-16. doi: 10.1128/JVI.01651-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795425 Free PMC article.
K18-hACE2 Mice for Studies of COVID-19 Treatments and Pathogenesis Including Anosmia.
Zheng J, Roy Wong LY, Li K, Verma AK, Ortiz M, Wohlford-Lenane C, Leidinger MR, Knudson CM, Meyerholz DK, McCray PB, Perlman S. Zheng J, et al. Among authors: perlman s. bioRxiv [Preprint]. 2020 Aug 10:2020.08.07.242073. doi: 10.1101/2020.08.07.242073. bioRxiv. 2020. Update in: Nature. 2021 Jan;589(7843):603-607. doi: 10.1038/s41586-020-2943-z. PMID: 32817939 Free PMC article. Updated. Preprint.
Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19.
Wong LR, Zheng J, Wilhelmsen K, Li K, Ortiz ME, Schnicker NJ, Pezzulo AA, Szachowicz PJ, Klumpp K, Aswad F, Rebo J, Narumiya S, Murakami M, Meyerholz DK, Fortney K, McCray PB Jr, Perlman S. Wong LR, et al. Among authors: perlman s. bioRxiv [Preprint]. 2021 Apr 21:2021.04.20.440676. doi: 10.1101/2021.04.20.440676. bioRxiv. 2021. PMID: 33907749 Free PMC article. Preprint.
The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.
Ye G, Gallant J, Zheng J, Massey C, Shi K, Tai W, Odle A, Vickers M, Shang J, Wan Y, Du L, Aihara H, Perlman S, LeBeau A, Li F. Ye G, et al. Among authors: perlman s. Elife. 2021 Aug 2;10:e64815. doi: 10.7554/eLife.64815. Elife. 2021. PMID: 34338634 Free PMC article.
1,266 results